The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Indian pharma stocks fell sharply today, with Sigachi Industries leading the decline after reports of potential US tariffs on ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early diagnosis and treatment. Advances in antiviral ...

Nagpur: Tragedy struck a pharma company's unit in Nagpur district on Tuesday when a blast occurred in a glass line reactor, ...

Sigachi Industries' shares slipped 8.19% to Rs 54.05  on BSE.  Dishman Carbogen Amcis shares fell 5% to Rs  260.55 against ...

Based in Kuala Lumpur, Aman brings over two decades of HR experience across industries like finance and pharma. To him, ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...

James Moss, the director of cyber investigations at law firm Addleshaw Goddard, told Sky News the ICO's fine was "about as ...